Skip to content
    ARDT
    Earnings call· Jun 2026(Q2 FY26)

    Ardent Health Q2 FY26 earnings call ARDT

    Aug 5, 2026 Source

    Executive summary

    Ardent Health Q2 FY26 — Strong Operational Execution Offsets Volume Headwinds

    Ardent Health demonstrated strong operational agility in Q2 FY26, successfully mitigating volume headwinds through increased cost savings and favorable payer contract renegotiations. The company reaffirmed its full-year adjusted EBITDA guidance despite softer volumes, driven by a multi-year "Impact" program and strategic revenue cycle improvements. Management emphasized disciplined execution and accountability to deliver consistent financial results and long-term shareholder value.

    Highlights

    5

    • Contract labor spend reduced by 42% year-over-year.

    • Increased 2026 Impact program savings target to over $70 million, up from $55 million.

    • Successfully negotiated a key payer contract renewal expected to add $5-$10 million to 2026 adjusted EBITDA.

    • Operating cash flow of $197 million in Q2 FY26, up from $117 million a year ago.

    • Ended the quarter with total net leverage of 0.8 times and lease adjusted net leverage of 2.6 times.

    Concerns

    4

    • Surgeries declined 2.9% and admissions declined 1% in Q2 FY26.

    • Net patient service revenue per adjusted admission decreased 3.9% due to lower acuity service mix.

    • Exchange admissions declined 8% year-over-year.

    • Full-year 2026 revenue outlook is now biased towards the lower end of the $6.4-$6.7 billion range.

    Guidance & targets

    6
    CategoryTargetConfidence
    2026 Impact program savings target
    over $70 million
    high materiality
    High
    Additional earnings from payer recontracting
    $5 to $10 million
    medium materiality
    High
    Full-year 2026 revenue
    biased towards the lower end of our $6.4 to $6.7 billion range
    high materiality
    Medium
    Full-year 2026 adjusted EBITDA
    $485 to $535 million
    high materiality
    High
    Full-year 2026 exchange headwind
    $35 million
    medium materiality
    High
    Third quarter adjusted EBITDA
    improve from the $115 million in the second quarter and approach the first quarter adjusted EBITDA of $124 million
    medium materiality
    High

    Operational metrics

    21
    Contract labor spend reduction
    42%YoY
    Q2 FY26

    Reduced contract labor spend year-over-year.

    Contract labor as percentage of SW&B
    2.2%from 3.8% a year ago
    Q2 FY26

    Improved from the prior year.

    Adjusted admissions growth
    2.5%YoY
    Q2 FY26

    Company-wide adjusted admissions.

    Net patient service revenue per adjusted admission
    3.9%decrease
    Q2 FY26

    Reflecting the benefit in Q2 FY25 from the New Mexico DPP program, and lower acuity service mix in Q2 FY26.

    Exchange admissions decline
    8%YoY
    Q2 FY26

    Corresponding increase in self-pay, but trends were manageable.

    Salaries, Wages, and Benefits (SW&B) growth
    0.7%YoY
    Q2 FY26

    Managed labor expense very well during the quarter.

    Professional fee growth
    0.4%compared to 12.9% in Q1 FY26
    Q2 FY26

    Year-over-year growth slowed as expected.

    Supplies increase
    3.3%YoY
    Q2 FY26

    Company-wide supplies expense.

    Capital expenditures
    $39 million
    Q2 FY26

    Expected to ramp through the year.

    Stock repurchased
    $13 million
    Q2 FY26

    Part of the share repurchase authorization.

    Remaining share repurchase authorization
    $34 million
    as of June 30, 2026

    Authorization remaining at quarter end.

    Total cash
    $724 million
    as of June 30, 2026

    Cash balance at quarter end.

    Total debt outstanding
    $1.1 billion
    as of June 30, 2026

    Debt balance at quarter end.

    Total available liquidity
    $992 million
    end of Q2 FY26

    Liquidity at quarter end.

    Volume headwind
    approximately $25 million
    FY26

    From lower volumes in Q2 and lower volume expectations for the rest of the year.

    Offsetting actions (Impact savings + payer recontracting)
    $20 to $30 million
    FY26

    Expected to fully offset the volume headwind.

    Additional Impact program savings from workforce reductions
    $15 to $20 million
    FY26

    Higher than previously expected savings this year.

    Virtual nurses discharge completion rate
    58%
    June

    Early proof point of virtual care rollout with HelloCare AI.

    Hours spent monitoring patients reduction
    18%
    June

    Early proof point of virtual care rollout with HelloCare AI.

    Referrals and patient transfers growth
    low double digit
    current

    Positive signals about potential business.

    Ambience Scribes productivity gain
    greater than a mid single digit improvement
    current

    Time savings for providers, still working through translation to additional visits.

    Industry KPIs

    5
    MetricValueDetails
    Utilization trends2.9% (surgeries); 1% (admissions); 2.5% (adjusted admissions)%
    Same facility volumes2.9% (surgeries); 1% (admissions); 2.5% (adjusted admissions)%
    Payer mix supplemental payments8%%
    Membership covered lives by line8%%
    Adjusted EPS EBITDA leverage guidance$115 million (Q2 FY26); $485 to $535 million (FY26 guidance)USD

    Deals & partnerships

    4
    EnsemblStrategic partnership to strengthen revenue cycle capabilities.

    Partnership with Ensemble is strengthening the company's revenue cycle capabilities.

    EpicStrategic partnership to strengthen clinical capabilities.

    Partnership with Epic is strengthening the company's clinical capabilities.

    HelloCare AIVirtual care platform rollout.

    Virtual care rollout with HelloCare AI is an early proof point, deployed in Texas and Idaho.

    VariousAcquiring and/or building urgent care and ASC facilities.

    Over the past two years, Ardent has acquired and/or built over 25 urgent care and ASC facilities.

    Risks & headwinds

    4
    Challenging volume environment / Volume softnessQ2 FY26, expected to continue in H2 FY26

    Surgeries declined 2.9% and admissions declined 1% in Q2 FY26. Revenue outlook biased to lower end of $6.4-$6.7 billion range.

    Mitigation: Increased Impact program savings target to over $70M, $15-20M additional savings from workforce reductions, $5-10M from payer recontracting. Flexed staffing and implemented additional non-clinical actions.

    Lower acuity service mixQ2 FY26

    Net patient service revenue per adjusted admission decreased 3.9%.

    Mitigation: Service line rationalization, moving lower margin procedures (ENT, ophthalmology) out of hospitals to free up capacity for higher margin service lines.

    Exchange admissions decline / Self-pay increaseQ2 FY26, FY26

    Exchange admissions declined 8% YoY. Reaffirming $35M exchange headwind for FY26.

    Mitigation: Trends were manageable and largely contemplated in original guidance. Data indicates a material portion of individuals losing exchange coverage find other insurance coverage.

    Macroeconomic pressure / Economic uncertaintyCurrent

    Not explicitly quantified, but cited as a driver for volume weakness in April/May, especially in high-deductible plans.

    Mitigation: Focus on operational rigor, Impact program, and controlling controllables regardless of the volume environment.

    What to watch in Q3 FY26

    5

    Volume trends (surgeries, admissions)

    Q3 FY26
    CurrentQ2 surgeries down 2.9%, admissions down 1%. June/July showed modest growth.
    TargetContinued improvement from Q2 levels, potentially exceeding conservative H2 assumptions.

    Why it matters

    Volume recovery is key to revenue growth and overall profitability, especially given current conservative guidance.

    Although July volumes are still below our original expectations entering this year, like June, they are improved from April and May volumes.

    Q&A highlights

    8

    How many more markets offer opportunities for improved payer contract rates, similar to the recent successful renewal?

    Management believes there are opportunities across most markets. They have integrated revenue integrity with contracting and are taking a more data-driven approach, asserting the need to be paid fairly.

    “I would say that there is opportunity across most of our markets for improvement.”

    asked by Ann Hynes · answered by Alfred Lumsdaine

    2 min read5 chapters

    Detailed Narrative

    01

    Operational Excellence & Impact Program

    Ardent Health's 'Impact program' is a multi-year strategic imperative focused on operational excellence. The company increased its 2026 savings target to over $70 million, up from an original $40 million and prior $55 million. Key initiatives include reducing contract labor spend by 42% year-over-year, streamlining managerial layers for $15-$20 million in additional savings this year, and leveraging technology partnerships with Epic and Ensemble to strengthen revenue cycle and clinical capabilities. These actions are largely non-clinical and aim to improve accountability and execution speed.

    02

    Payer Contracting Strategy

    The company is implementing a more disciplined, data-driven approach to payer contracting, utilizing price transparency data to identify and address rates below market benchmarks. An early success was a June renewal with a key payer in one market, which improved both rates and terms, expected to add $5-$10 million to 2026 adjusted EBITDA. Management believes there are opportunities across most markets to enhance revenue yield through these strategies, despite the challenging nature of negotiations.

    03

    Volume Dynamics & Mitigation

    Ardent experienced broad-based volume softness in April and May, with surgeries down 5% and admissions down 2% year-over-year. While these trends improved to modest growth in June and July, full Q2 surgeries declined 2.9% and admissions declined 1%. To mitigate the approximately $25 million headwind from lower volumes, the company quickly flexed staffing, implemented non-clinical actions, and relied on the increased Impact program savings and payer recontracting benefits, which are expected to be at full run-rate by Q3.

    04

    Strategic Growth & Service Line Rationalization

    Ardent continues to expand its access points by acquiring or building over 25 urgent care and ASC facilities, aiming to capture market share in attractive, fast-growing markets. The company is organizing around high-value service lines such as cardiology and women's and children's, guided by its 'Capacity IQ' framework to match demand with capacity. Additionally, lower-margin procedures like ENT and ophthalmology are being rationalized and moved out of hospitals to free up capacity for higher-margin services, optimizing asset utilization.

    05

    Technology & AI Adoption

    Technology plays a crucial role in Ardent's strategy, with partnerships like Epic and Ensemble strengthening core operations. The rollout of virtual care with HelloCare AI in Texas and Idaho has shown early success, with virtual nurses completing 58% of discharges in June and reducing patient monitoring hours by 18%. The company also leverages AI for denial management recovery efforts and has seen significant productivity gains (greater than mid-single digit improvement) from ambient listening technologies like Ambience Scribes for providers.

    AI-generated summary of the company’s earnings call. Not investment advice.